OPRX Shareholders Approve 1 Million Share Increase to 2021 Equity Incentive Plan

OptimizeRx Corporation announced that shareholders approved an amendment to its 2021 Equity Incentive Plan at the Annual Meeting on June 9, 2026. The amendment increases the number of common stock shares available for issuance as awards under the plan.

Key Details

• Share Increase: The number of shares available under the plan was increased by 1,000,000, bringing the new aggregate total to 5,450,000 shares of common stock.
• Rejected Proposal: A separate proposal to add an "evergreen" provision, which would have automatically increased the share reserve annually, was not approved by shareholders.
• Meeting Outcomes: All seven director nominees were elected, executive compensation was approved on an advisory basis, and Grant Thornton, LLP was ratified as the independent registered public accounting firm for 2026.